Saskatchewan River Sturgeon Management Board

EQS-News: wienerberger expands its sustainability commitments

Retrieved on: 
Tuesday, November 7, 2023

wienerberger publishes sustainability program 2026, which builds on the sustainability program 2023 and sets new, even more ambitious goals

Key Points: 
  • wienerberger publishes sustainability program 2026, which builds on the sustainability program 2023 and sets new, even more ambitious goals
    Further reduction of CO2 emissions, increased circularity, and improved biodiversity
    Vienna, November 6, 2023 – As a next step on the path towards achieving climate neutrality 2050, wienerberger has upgraded its sustainability commitments in accordance with its three-year-rhythm.
  • Heimo Scheuch, Chairman of the Managing Board of Wienerberger AG: “The fact that our Sustainability Program 2023 has been a success motivates us to increase our efforts.
  • Emissions stemming from outside the company, including purchased services and transport, will be cut by 10% as wienerberger focuses on low-emission suppliers.
  • As a new social goal within the Sustainability Program 2026, wienerberger continues its focus on personal health and safety, further striving towards the principle of zero harm.

EQS-News: Lenzing implements comprehensive performance program in response to lack of market recovery

Retrieved on: 
Tuesday, November 7, 2023

We already launched an ambitious cost-cutting program at the end of 2022, which has delivered the expected results ahead of schedule.

Key Points: 
  • We already launched an ambitious cost-cutting program at the end of 2022, which has delivered the expected results ahead of schedule.
  • Building on this, the Managing Board is currently implementing a comprehensive performance program with the overriding objective of significantly enhanced long-term resilience to crises and greater agility in the face of market changes.
  • Lenzing is therefore able to generate 100 percent of its fiber sales with specialty fibers from the TENCEL™, LENZING™ ECOVERO™ and VEOCEL™ brands.
  • The general market environment is continuing to weigh on the consumer climate and on sentiment in the industries relevant to Lenzing.

EQS-News: CLIQ Digital AG: Quarter-on-quarter sales growth of 8% and €15m operating free cash flow in 9M 2023

Retrieved on: 
Tuesday, November 7, 2023

Regionally, North American and European sales in 9M 2023 grew by 29% and 18% respectively.

Key Points: 
  • Regionally, North American and European sales in 9M 2023 grew by 29% and 18% respectively.
  • The market environment in Europe remained competitive but sales in Latin America increased significantly to €9m million in 9M 2023.
  • Customer acquisition costs (marketing spend): In 9M 2023, the customer acquisition costs grew by 21% to €100 million (PY: €83 million).
  • Cash flow & liquidity: Operating free cash flow in 9M 2023 was €15 million (PY: €7 million).

EQS-News: TeamViewer with high 44% margin and 10% revenue growth in Q3 2023; on track to reach full year guidance

Retrieved on: 
Tuesday, November 7, 2023

On the back of this, the definition of the Adjusted EBITDA changed from a Billings to a Revenue perspective.

Key Points: 
  • On the back of this, the definition of the Adjusted EBITDA changed from a Billings to a Revenue perspective.
  • During Q3, TeamViewer has worked on a major update of the Tensor solution, which was released end of October.
  • The company delivered a solid 10% revenue growth in Q3 2023 while the Adjusted (Revenue) EBITDA grew even stronger, by 19%, resulting in a high 44% margin.
  • The early extension of his contract will allow him to focus on further developing and executing TeamViewer’s growth strategy.

Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights

Retrieved on: 
Tuesday, October 31, 2023

This will enable the company to deliver meaningful additional data which will be important in fulfilling the longer-term potential of our pipeline.

Key Points: 
  • This will enable the company to deliver meaningful additional data which will be important in fulfilling the longer-term potential of our pipeline.
  • The planned Phase II proof-of-concept study will be the first to treat patients suffering from pulmonary sarcoidosis and is expected to start in the fourth quarter 2023.
  • Molecure signed an agreement with Simbec-Orion, a leading global Clinical Research Organization which will conduct the clinical trial on behalf of Molecure.
  • This was mainly due to higher research costs as the company’s pipeline advances, higher salaries and costs of external services.

Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023

Retrieved on: 
Tuesday, October 31, 2023

Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.

Key Points: 
  • Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
  • Scientific and medical experts from across Fresenius Medical Care will present research related to many important topics in kidney disease care.
  • Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius Medical Care Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical Dataset

Retrieved on: 
Thursday, October 26, 2023

"The data created across Fresenius Medical Care's global clinical footprint is unmatched in its breadth and depth, and is one of the company's greatest competitive advantages," said Stuart McGuigan, Global Chief Information Officer of Fresenius Medical Care.

Key Points: 
  • "The data created across Fresenius Medical Care's global clinical footprint is unmatched in its breadth and depth, and is one of the company's greatest competitive advantages," said Stuart McGuigan, Global Chief Information Officer of Fresenius Medical Care.
  • Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
  • Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

EQS-News: Blue Cap AG publishes key financial figures for the third quarter of 2023 and provides an outlook for further development

Retrieved on: 
Thursday, October 26, 2023

The growth strategy also includes plans for a noticeable increase in portfolio transactions in German “Mittelstand”.

Key Points: 
  • The growth strategy also includes plans for a noticeable increase in portfolio transactions in German “Mittelstand”.
  • Blue Cap AG operates active portfolio management in its investments, which was further strengthened with the introduction of the transformation radar at the beginning of 2023.
  • In recent months, Blue Cap has proven that it can quickly identify and implement necessary measures.
  • Henning Eschweiler, COO of Blue Cap, comments: “With these skills in the team, we are also ideally prepared for increasing value in special situations.

EQS-News: ATOSS Software AG: Munich’s workforce specialist continues to show strong growth and high profitability in the third quarter – guidance for 2023 raised

Retrieved on: 
Thursday, October 26, 2023

In the third quarter of 2023, ATOSS Software AG succeeded in maintaining its dynamic growth of the first half of the year, achieving new revenues and earnings record.

Key Points: 
  • In the third quarter of 2023, ATOSS Software AG succeeded in maintaining its dynamic growth of the first half of the year, achieving new revenues and earnings record.
  • ATOSS Software AG can look back on a very successful third quarter with new highs for revenues and earnings.
  • The company’s dynamic growth was again boosted impressively in spite of the downturn in the economic environment.
  • The order book of the Munich software specialist for workforce management solutions enjoyed pleasing growth overall.

EQS-News: 2G Energy AG: Order intake recovers in Q3 in line with expectations and exceeds the previous year by 12%

Retrieved on: 
Thursday, October 26, 2023

The major order from Israel recorded in July totaling 6.1 million euros is being pursued as planned.

Key Points: 
  • The major order from Israel recorded in July totaling 6.1 million euros is being pursued as planned.
  • The 2G Energy AG Group is an internationally leading manufacturer and system provider of decentralized energy supply systems.
  • With its products and services, 2G is at the interface to a decentralized, secure and largely decarbonized energy supply.
  • The shares of 2G Energy (ISIN DE000A0HL8N9) are listed in the “Scale” segment of the Frankfurt Stock Exchange.